{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T14:35:00Z","timestamp":1773498900150,"version":"3.50.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","jpedsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Surgery"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.jpedsurg.2017.12.001","type":"journal-article","created":{"date-parts":[[2017,12,16]],"date-time":"2017-12-16T12:56:48Z","timestamp":1513429008000},"page":"1330-1333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Postoperative complications of pediatric patients with inflammatory bowel disease treated with vedolizumab"],"prefix":"10.1016","volume":"53","author":[{"given":"Lori A.","family":"Zimmerman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill M.","family":"Zalieckas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Shamberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athos","family":"Bousvaros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jpedsurg.2017.12.001_bb0005","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1053\/j.gastro.2008.06.079","article-title":"Natural history of pediatric Crohn's disease: a population-based cohort study","volume":"135","author":"Vernier-Massouille","year":"2008","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.jpedsurg.2017.12.001_bb0010","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0022-3468(97)90400-0","article-title":"Surgery for Crohn's disease in infants and children","volume":"32","author":"Patel","year":"1997","journal-title":"J Pediatr Surg"},{"issue":"4","key":"10.1016\/j.jpedsurg.2017.12.001_bb0015","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1053\/j.gastro.2006.02.003","article-title":"Risk factors for initial surgery in pediatric patients with Crohn's disease","volume":"130","author":"Gupta","year":"2006","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jpedsurg.2017.12.001_bb0020","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/MEG.0000000000000761","article-title":"The natural history of Crohn's disease in children: a review of population-based studies","volume":"29","author":"Duricova","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.jpedsurg.2017.12.001_bb0025","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.dld.2008.03.014","article-title":"Colectomy rate in acute severe ulcerative colitis in the infliximab era","volume":"40","author":"Aratari","year":"2008","journal-title":"Dig Liver Dis"},{"issue":"3","key":"10.1016\/j.jpedsurg.2017.12.001_bb0030","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/apt.13478","article-title":"Review article: the natural history of paediatric-onset ulcerative colitis in population-based studies","volume":"43","author":"Fumery","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.jpedsurg.2017.12.001_bb0035","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1215734","article-title":"Vedolizumab as induction and maintenance therapy for ulcerative colitis","volume":"369","author":"Feagan","year":"2013","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jpedsurg.2017.12.001_bb0040","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1215739","article-title":"Vedolizumab as induction and maintenance therapy for Crohn's disease","volume":"369","author":"Sandborn","year":"2013","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jpedsurg.2017.12.001_bb0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/ecco-jcc\/jjw147","article-title":"Postoperative outcomes in vedolizumab-treated patients undergoing abdominal operations for inflammatory bowel disease","volume":"11","author":"Lightner","year":"2017","journal-title":"J Crohns Colitis"},{"issue":"8","key":"10.1016\/j.jpedsurg.2017.12.001_bb0050","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1007\/s00595-017-1481-2","article-title":"The influence of specific technical maneuvers utilized in the creation of diverting loop-ileostomies on stoma-related morbidity","volume":"47","author":"Miyo","year":"2017","journal-title":"Surg Today"},{"issue":"7","key":"10.1016\/j.jpedsurg.2017.12.001_bb0055","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1097\/MIB.0000000000000373","article-title":"Efficacy and safety of natalizumab and vedolizumab for the management of Crohn's disease: a systematic review and meta-analysis","volume":"21","author":"Chandar","year":"2015","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.jpedsurg.2017.12.001_bb0060","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MPG.0000000000001151","article-title":"Postoperative complications in children with Crohn disease treated with infliximab","volume":"63","author":"Zimmerman","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Journal of Pediatric Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346817308242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346817308242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T21:37:53Z","timestamp":1530135473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022346817308242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0022346817308242"],"URL":"https:\/\/doi.org\/10.1016\/j.jpedsurg.2017.12.001","relation":{},"ISSN":["0022-3468"],"issn-type":[{"value":"0022-3468","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Postoperative complications of pediatric patients with inflammatory bowel disease treated with vedolizumab","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpedsurg.2017.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}